BioSpace News Archive

Dr. Phil Doren, Chief Executive Officer, announced that Dr. Susan Walker is a member of the Board of Directors of Abond CRO Inc.

Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise.

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it is exploring the potential of using NP-120 as a novel treatment for COVID-19, also known as the coronavirus.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that the European Commission has granted marketing authorization to its HCV collaboration partner AbbVie for MAVIRET® (glecaprevir/pibrentasvir) to shorten the once-daily treatment duration from 12 to 8 weeks in treatment-naïve, compensated cirrhotic, chronic HCV patients with genotype (GT) 3 infection.

Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its fourth quarter and year-end 2019 financial results prior to the opening of U.S. financial markets on Friday, March 13, 2020.

The Georgia Dental Association Foundation for Oral Health has launched “Healthy Mouth, Healthy Me!,” a new effort to educate Georgians about the connection between dental health and overall health.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of an inducement equity award to a newly hired employee.

KB Home (NYSE: KBH) today announced that it is the first homebuilder to join the Well Living Lab Alliance, a collaboration of Delos and Mayo Clinic, which is supported by a global consortium and dedicated to the advancement of knowledge to transform indoor environments, and ultimately improve human health and well-being

A recent article published in “ACR Open Rheumatology” found that rheumatologist care was associated with better disease management for patients with advanced gout verses care from general practitioners.

Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced appointment of Ms. Cathy Peng as a member of the Board of Directors of the Company effective March 6, 2020 to replace Mr. Zhang Jianbin who step down due to personal reasons.